Medical Director, Anatomic Pathology, Cleveland Clinic Laboratories
Cleveland Clinic
Scott Kilpatrick, MD is currently a Professor of Pathology, Director, Orthopaedic Pathology & Co-Director, ePathology (Telepathology), at the Cleveland Clinic. He is a pathologist who specializes in bone and soft tissue, both neoplastic and non-neoplastic disease. Dr. Kilpatrick was raised in the southeastern United States, more specifically the state of Georgia and the city of Atlanta. He obtained a B.S. Degree in Biology at the University of Georgia, Athens, Georgia, and his M.D. degree at the Medical College of Georgia in Augusta. Following residency in Anatomic and Clinic Pathology at the Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, he completed a surgical pathology fellowship, specializing in Bone and Soft Tissue Pathology, at the Mayo Clinic, Rochester, Minnesota. Previous sites of employment have included both private practice and academic appointments, initially at Wake Forest University Baptist Medical Center, followed by the University of North Carolina, Chapel Hill, where he served as Director of Surgical Pathology. He joined the Cleveland Clinic in 2016. His research includes diseases of the skeleton and connective tissues, focusing predominantly on clinicopathological analyses, correlation of immunohistochemical, cytogenetic, and molecular findings, and the use of fine needle aspiration biopsy. Contributions to the literature encompass over 100 publications, book chapters, and a textbook, entitled Diagnostic Musculoskeletal Surgical Pathology. His recent literature contributions include topics related to Ewing sarcoma, a novel primary bone neoplasm “atypical sclerosing osteoblastic neoplasm”, the significance of calcium pyrophosphate dihydrate disease (pseudogout) in total joint resections, avascular necrosis and the necessity to pathologically evaluate femoral heads (hip arthroplasties), and updating and clarifying the criteria for dedifferentiated liposarcoma.
